Accelerating the introduction of rotavirus immunization in Indonesia.
نویسندگان
چکیده
The introduction of the rotavirus vaccine in Indonesia is currently in its infancy. Delay in its development might be caused by factors related to the perceived value of the vaccine, health system characteristics and policy considerations. Other factors, which may also interfere with optimizing the introduction, are financial barriers because Indonesia is a lower-middle-income country. Creating fiscal space to finance new immunization programs, such as for the rotavirus immunization, is very important to ensure the sustainability of new programs so that such programs would be financed over the long term and not endanger the sustainability of the Indonesian government's financial position. This article provides an illustration of the various steps needed to accelerate the introduction of the rotavirus immunization.
منابع مشابه
Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
BACKGROUND Rotavirus infection has been reported to be responsible for the majority of severe diarrhea in children under-5-years-old in Indonesia. Breast milk is considered to give protection against rotavirus infection. Increasing breastfeeding promotion programs could be an alternative target to reduce the incidence of rotavirus diarrhea. This study aims to investigate the effect of breastfee...
متن کاملCloning of Rota Virus Outer Capsid Protein (VP7) Gene into the pGEM Vector
Background and Aims: In humans the group A rotaviruses are associated with endemic diarrhea in children under the age of 5, leading to approximately 800,000 deaths every year. Introduction of rotavirus vaccines into childhood immunization programs can contribute to substantial reduction in mortality from rotavirus gastroenteritis in developing countries and virtually eliminating hospitalization...
متن کاملPublic health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States
We developed a cohort model to evaluate the expected public health impact of accelerated regimens for immunization against rotavirus gastroenteritis (RVGE). Alternative strategies for vaccination with the pentavalent human-bovine reassortant vaccine, Rotateq(®) (RV5, Merck) and the oral live attenuated human rotavirus vaccine, Rotarix(®) (RV1, GlaxoSmithKline Vaccines) were considered, includin...
متن کاملبررسی فراوانی و دمو گرافیک گاستروانتریت حاد روتاویروسی در کودکان بستری شده در شهر برازجان از سال 1387 تا 1388
Introduction: Rotaviruses are one of the most important causes of severe viral gastroenteritis and death among children, worldwide. The aim of this study was to determine the prevalence of Rotavirus gastroenteritis in hospitalized children of Borazjan. Methods: This cross sectional – descriptive study was done on 375 stool samples of children younger than 7 years old hospitalized in 17 Shahri...
متن کاملBuilding Laboratory Capacity to Support the Global Rotavirus Surveillance Network
In 2001, in anticipation of rotavirus vaccine licensure and introduction, the World Health Organization (WHO) and partners established regional laboratory surveillance networks for rotavirus detection and strain type monitoring among hospitalized children aged <5 years. In 2006, two WHO-prequalified oral rotavirus vaccines were licensed: a 2-dose, single-strain vaccine (Rotarix, GlaxoSmithKline...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Expert review of vaccines
دوره 13 4 شماره
صفحات -
تاریخ انتشار 2014